Tag Archives: Joint technology initiative

ENIAC

ENIAC

Outline of the Community (European Union) legislation about ENIAC

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Research and innovation > Research in support of other policies

ENIAC

Document or Iniciative

Council Regulation (EC) No 72/2008 of 20 December 2007 setting up the ENIAC Joint Undertaking.

Summary

The ENIAC Joint Undertaking implements the Joint Technology Initiative (JTI) on nanoelectronics with a view to developing information and communication technologies. This public-private partnership aims to support investments in this area, sources of innovation and competitiveness. The JTI on nanoelectronics is thus also part of the European Research Area (ERA) and contributes to research and development (R&D).

Based in Brussels, the Joint Undertaking is a Community body with legal personality. It was set up for a period extending until 31 December 2017. The founding members of the Joint Undertaking are the Community, Belgium, Germany, Estonia, Ireland, Greece, Spain, France, Italy, the Netherlands, Poland, Portugal, Sweden, the United Kingdom and the AENEAS association, which represents companies and other R&D actors operating in the field of nanoelectronics. The ENIAC Joint Undertaking is open to new members. Up to now, Austria, the Czech Republic and Norway have joined the list of members.

Objectives

The ENIAC Joint Undertaking is to contribute to the implementation of the Seventh Framework Programme for research, technological development and demonstration activities (Seventh Framework Programme) in the field of nanoelectronics. One of its key objectives is to encourage the development of essential skills by means of a research programme and to support its activities. It is thus aimed at encouraging European competitiveness as well as the emergence of new markets and new social applications. Small and medium-sized enterprises (SMEs) are also encouraged to participate.

The Joint Undertaking also aims to promote cooperation and the coordination of Community and national efforts, both public and private, in order to support R&D and investment: concentrating efforts will, in particular, make it possible to ensure that better use is made of results.

Operation

The Joint Undertaking consists of the following bodies:

  • The governing board, made up of representatives of the members of the ENIAC Joint Undertaking and the chairperson of the industry and research committee. It ensures the smooth running of the organisation and supervises the implementation of its activities;
  • The executive director, appointed for a three-year period by the governing board, is the main person responsible for day-to-day management and is the legal representative of the Joint Undertaking;
  • The public authorities board, made up of the public authorities of the Joint Undertaking which appoints their representatives and their lead delegate. Its role includes approving the scope and the launch of calls for proposals and deciding on the selection and financing of accepted proposals;
  • The industry and research committee, comprising a maximum of 25 members, is appointed by the AENEAS association. It is responsible in particular for drawing up the multiannual strategic plan and for drafting proposals concerning the Joint Undertaking’s strategy.

ENIAC’s resources consist of contributions from members and from the Community as well as revenue generated by ENIAC itself. Any legal entity that is not a member may make a contribution to ENIAC’s resources either in cash or in kind.

ENIAC’s costs consist of:

  • Operating costs, borne by its members. AENEAS also makes a contribution of up to EUR 20 million or at most 1 % of the sum of total costs for all projects. The Community’s contribution may not exceed the sum of EUR 10 million. ENIAC Member States make a contribution in kind;
  • R&D activities. The Community makes a contribution of up to EUR 440 million. The financial contributions of ENIAC Member States, equivalent to at least 1.8 times the contribution made by the Community, do not pass through the Joint Undertaking but are paid directly to the research and development bodies participating in the projects. Furthermore, those same bodies make contributions in kind whose value is equivalent to at least half the total cost of R&D activities.

R&D activities are implemented by means of projects launched as a result of competitive calls for proposals. These projects are financed by financial contributions from the Community and from participating Member States and by contributions in kind from the research and development bodies participating in the Joint Undertaking’s projects.

As a Community initiative, the Joint Undertaking and its staff are covered by Community legislation. In particular, the Court of Justice of the European Communities is the authority responsible for ruling on any proceedings between members and on proceedings brought against the ENIAC Joint Undertaking. The Commission and the Court of Auditors carry out checks on recipients of any Joint Undertaking finance.

Background

The Lisbon Agenda for Growth and Jobs placed emphasis on investment in the fields of knowledge and innovation. Therefore the JTIs, public-private partnerships implemented by Joint Undertakings, have been initiated under the Seventh Framework Programme. These JTIs stem from the work of European Technology Platforms set up under the Sixth Framework Programme.

With the “ENIAC” initiative, five other JTIs are planned in the following sectors: embedded computing systems (ARTEMIS), innovative medicines (IMI), aeronautics and air transport (CLEAN SKY), hydrogen and fuel cells (FUEL CELL), and Global Monitoring for Environment and Security (GMES).

References

Act Entry into force Timescale for transposition into Member States Official Journal
Regulation (EC) No. 72/2008

7.2.2008

OJ L 30, 4.2.2008

Clean Sky

Clean Sky

Outline of the Community (European Union) legislation about Clean Sky

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Environment > Air pollution

Clean Sky

Document or Iniciative

Council Regulation (EC) No 71/2008 of 18 December 2007 setting up the Clean Sky Joint Undertaking.

Summary

The “Clean Sky” joint technology initiative (JTI) is part of the “Cooperation” specific programme (7th framework programme for research and technological development).

Aims

Created to run until 31 December 2017, Clean Sky aims principally to:

  • accelerate the development of clean air transport technologies;
  • guarantee effective coordination of aeronautics research on a European scale;
  • set up an innovative and competitive air transport system;
  • improve knowledge generation and use of research findings.

In terms of figures, “Clean Sky” aims to reduce CO2 emissions by 50 %, NOx by 80 % and noise pollution by 50 % by 2020.

“Integrated Technology Demonstrators” (ITD)

Six technical domains, covering all aspects of aircraft technology and known as “integrated technology demonstrators” form the structure of “Clean Sky”. They provide a framework for research operations from the experimental phase to in-flight demonstrations.

Specifically, the six ITD are:

  • the Smart Fixed Wing ITD targeting wing technologies;
  • the Green Regional Aircraft ITD (engines, energy management and new silent configurations);
  • the Green Rotorcraft ITD targeting installation of innovative blades and engines which are quieter, reduce drag, are more fuel-efficient and use environmentally-friendly flight paths;
  • the Systems for Green Operations ITD targeting equipment, architecture and thermal management;
  • the Sustainable and Green Engines ITD integrating technologies for quiet, low weight, low pressure systems and reducing nitrogen oxides (NOx);
  • the Eco-Design ITD, which will focus on the full life cycles of materials and components (design, manufacture, maintenance and destruction/recycling).

An independent technical evaluator will assess and monitor the results of research carried out in these various sectors in order to optimise the impact of the programme in terms of achieving its environmental objectives.

Members and bodies

Its founding members are:

  • the European Union (EU) represented by the Commission;
  • twelve ITD leaders and associates;
  • any public or private entity (industry, company, SME, research centre, university, etc.) established in a Member State or in a country associated with the 7th Framework Programme which, under certain conditions and subject to the consent of the governing board, may request membership.

Its bodies are:

  • the Governing Board;
  • the Executive Director;
  • the ITD Steering Committees;
  • the Technology Evaluator Steering Committee;
  • the General Forum.

A National States Representative Group will act as an external advisory body to the undertaking.

Budget

The maximum Community contribution will be EUR 800 million paid from the budget appropriation allocated to the “Transport” theme of the “Cooperation” Specific Programme. Added to this is a contribution which is at least equivalent from the other members of the undertaking, giving a total budget of EUR 1.6 billion.

General information

As a Community body, “Clean Sky” has legal status.

Further information on the objectives and activities of the “Clean Sky” JTI, its status and operation, the role and tasks of its members and bodies, and its funding, are available in the annex to the Regulation.

Background

In addition to “Clean Sky”, five other initiatives of this type are planned in the areas of miniaturisation (ENIAC), invisible information systems (ARTEMIS), innovative medicine, hydrogen and fuel cells and global monitoring for environment and security (GMES).

References

Act Entry into force – Date of expiry Deadline for transposition in the Member States Official Journal

Regulation (EC) No 71/2008

7.2.2008 – 31.12.2017

OJ L 30 of 4.2.2008

The successive amendments and corrections to Regulation (EC) No 71/2008 have been integrated into the original text. This consolidated versionis for reference only.

IMI Joint Undertaking

IMI Joint Undertaking

Outline of the Community (European Union) legislation about IMI Joint Undertaking

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Research and innovation > Research in support of other policies

IMI Joint Undertaking

Document or Iniciative

Council Regulation (EC) No 73/2008 of 20 December 2007 setting up the Joint Undertaking for the implementation of the Joint Technology Initiative on Innovative Medicines.

Summary

The IMI Joint Undertaking implements the Joint Technology Initiative (JTI) on Innovative Medicines, with a view to the development of a competitive, innovation-based pharmaceuticals sector. This public-private partnership aims to support investments in this field.

The IMI Joint Undertaking is a Community body possessing legal personality. Its headquarters are in Brussels. This undertaking has been set up for a period up to 31 December 2017. Its founding members are the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Any legal entity directly or indirectly supporting research and development in a Member State or in a country associated with the 7th Framework Programme (7th FP) may become a member of the IMI Joint Undertaking.

Objectives

The Joint Undertaking aims to improve the efficiency and effectiveness of the medicine development process so that the pharmaceutical sector produces safer and more effective innovative treatments. The objectives of the Joint Undertaking are thus to contribute to the implementation of the 7th FP and to support pharmaceutical research and development in the Member States and countries associated with the 7th FP. The participation of small and medium-sized enterprises (SMEs) and cooperation with the private sector and the academic world are encouraged.

In addition, the Joint Undertaking aims to ensure complementarity with other activities of the 7th FP and to establish a public-private partnership with a view to increasing research investment and fostering cooperation between the public and private sectors.

Projects and activities

The IMI Joint Undertaking supports prospective research activities, based on projects selected following open and competitive calls for project proposals, independent evaluation and the conclusion of grant agreements and project agreements.

The participating research-based pharmaceutical companies that are members of EFPIA are not eligible to receive financial support from the IMI Joint Undertaking for any activity.

Operation

The bodies of the IMI Joint Undertaking are as follows:

  • the Governing Board is composed of representatives of each of the members of the Joint Undertaking. It is responsible for operations and for overseeing the implementation of activities. It meets at least twice a year;
  • the Executive Director represents the IMI Joint Undertaking from a legal point of view. He or she is also the chief executive responsible for the day-to-day management of the Undertaking in accordance with the decisions taken by the Governing Board;
  • the Scientific Committee is the advisory body to the Governing Board, with responsibilities including advising on the scientific priorities for the annual implementation plan proposal.

The IMI Joint Undertaking is supported by two external advisory bodies:

  • the IMI States Representatives Group consists of one representative of each Member State and of each country associated with the Framework Programme. It advises on the annual scientific priorities. Furthermore, it also informs the IMI Joint Undertaking on relevant activities ongoing at national level;
  • the Stakeholder Forum is convened at least once a year by the Executive Director. It is informed on the activities of the IMI Joint Undertaking and provides comments.

The financial resources of the Joint Undertaking include members’ financial contributions, revenue generated by the IMI Joint Undertaking and any other financial contributions, resources and revenues.

The research activities are funded through non-monetary contributions by the research-based pharmaceutical companies that are members of EFPIA, contributions from members and a Community financial contribution under the 7th FP. This financial commitment on the part of the Community is limited to a maximum of EUR 1 000 million.

Context

Under the 7th Community FP, the EU provides for the establishment of long-term public-private partnerships in the form of JTIs. These JTIs result from the work of European Technology Platforms set up under the 6th FP and implemented through Joint Undertakings.

In addition to the IMI, five other JTIs are planned in the sectors of spaceborne computer systems (ARTEMIS), nanotechnologies (ENIAC), aeronautics and air transport (Clean Sky), hydrogen and fuel cells (FUEL CELL) and Global Monitoring for Environment and Security (GMES).

References

Act Entry into force – Expiry date Deadline for transposition in the Member States Official Journal

Regulation (EC) No 73/2008

7.2.2008-31.12.2017

OJ L 30, 4.2.2008

ARTEMIS

ARTEMIS

Outline of the Community (European Union) legislation about ARTEMIS

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Research and innovation > Research in support of other policies

ARTEMIS

Document or Iniciative

Council Regulation (EC) No 74/2008 of 20 December 2007 on the establishment of the ARTEMIS Joint Undertaking to implement a Joint Technology Initiative in Embedded Computing Systems

Summary

From mobile phones to bank cards, cars and planes, integrated computing devices have become part and parcel of our daily lives.

They also represent a growing share in the value of finished goods in many key industrial sectors.

According to recent statistics, these technologies represent a true growth market:

  • 98 % of computers are integrated in other devices;
  • over 4 billion embedded systems were sold in 2007;
  • the world market comes to EUR 60 billion and is continuing to grow at an annual rate of 14 %;
  • by 2010, it is expected that over 16 billion embedded computers will be in circulation (over 40 billion by 2020).

The European Union (EU) has this market in its sights, focusing its efforts on a new Joint Undertaking, known as ARTEMIS.

The ARTEMIS Joint Undertaking implements the Joint Technology Initiative (JTI) on Embedded Computing Systems.

This public-private partnership aims essentially to support the co-financing of research initiatives at European level and to improve cooperation between the various operators in the sector.

Based in Brussels, the Joint Undertaking is a Community body with legal personality. It has been set up for a period up to 31 December 2017. The founding members of the Joint Undertaking are the Community (represented by the Commission), Belgium, Denmark, Germany, Estonia, Ireland, Greece, Spain, France, Italy, Hungary, the Netherlands, Austria, Portugal, Romania, Slovenia, Finland, Sweden, the United Kingdom and ARTEMISIA, an association representing companies and research and development (R&D) organisations active in the field of embedded computing systems. The ARTEMIS Joint Undertaking is open to new members.

Objectives

ARTEMIS contributes to the implementation of the Specific Programme “Cooperation” of the Seventh Framework Research and Development Programme (7th FRDP).

It aims in particular:

  • to define and implement a “Research Agenda” for the development of key technologies for embedded computing systems;
  • to provide financial support for various R&D activities;
  • to promote a public-private partnership favouring convergence of Community and national efforts (public and private), investments, and collaboration between the various sectors involved;
  • to improve the coordination of R&D efforts in the field of embedded computing systems;
  • to encourage the involvement of small and medium-sized enterprises (SMEs).

Functioning

The Joint Undertaking bodies are:

  • the Governing Board, which consists of representatives of the members of the ARTEMIS Joint Undertaking and the Chairperson of the Industry and Research Committee, has responsibility for the operations of the Joint Undertaking and oversees the implementation of its activities;
  • the Executive Director is appointed for a three-year period by the Governing Board, is responsible for the day-to-day management and is the legal representative of the Joint Undertaking;
  • the Public Authorities Board consists of the public authorities of the Joint Undertaking, each of which appoints its representatives and a lead delegate. Its tasks include approving the scope and the launch of calls for proposals and deciding the selection and funding of the proposals selected;
  • the Industry and Research Committee consists of a maximum of twenty-five members appointed by the ARTEMISIA association. Its tasks include preparing the draft Multiannual Strategic Plan and making proposals regarding the strategy of the Joint Undertaking.

The ARTEMIS resources are made up of contributions from the members and the Community and revenue generated by ARTEMIS itself. Any legal entity which is not a member may make in-kind or cash contributions to the ARTEMIS resources.

The ARTEMIS costs consist of:

  • running costs, borne by its members. ARTEMISIA also makes a contribution of up to EUR 20 million or up to 1 % of the sum of the total cost of all projects. The Community contribution may not exceed EUR 10 million. The ARTEMIS Member States make in-kind contributions;
  • R&D activities. The Community makes a contribution of up to EUR 410 million. The financial contributions from the ARTEMIS Member States amount to at least 1.8 times the Community’s financial contribution and do not pass through the Joint Undertaking, but are paid directly to the research and development organisations participating in the projects. Furthermore, the same bodies make in-kind contributions to the projects, the total value of which over the duration of the Joint Undertaking is equal to or greater than the contribution of the public authorities.

The R&D activities are implemented by means of projects launched following open and competitive calls for proposals. These projects are funded by financial contributions from the Community and the participating Member States and by in-kind contributions by the research and development organisations participating in the projects of the Joint Undertaking.

As a Community initiative, Community legislation applies to the Joint Undertaking, including its staff. The Court of Justice of the European Communities has jurisdiction in any dispute between the members and in actions brought against the ARTEMIS Joint Undertaking. The Commission and the Court of Auditors carry out checks among the recipients of the Joint Undertaking’s funding.

Background

The Lisbon Agenda for Growth and Jobs placed the emphasis on investment in knowledge and innovation. In this respect, JTIs, which are public-private partnerships implemented by joint undertakings, have been set up under the 7th FRDP. These JTIs stem from the work of European Technology Platforms set up under the 6th FRDP.

In addition to the “ARTEMIS” initiative, five other JTIs are planned in nano-electronics (ENIAC), innovative medicines (IMI), aeronautics and air transport (CLEAN SKY), hydrogen and fuel cells (FUEL CELL), and global monitoring for environment and security (GMES).

References

Act Entry into force Deadline for transposition in the Member States Official Journal
Regulation (EC) No 74/2008 [adoption: consultation CNS/ 2007/ 088] 7.2.2008 OJ L 30 of 4.2.2008